This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Alfresa Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Provides Commemorative Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Revises Consolidated Earnings Guidance for the First Half Ended September 30, 2023 and Fiscal Year March 31, 2024 CI
Alfresa Holdings Completes 35 Billion Yen Share Buyback program MT
Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2023. CI
Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2023. CI
Alfresa Holdings Corporation's Equity Buyback announced on May 15, 2023, has closed with 15,201,200 shares, representing 7.65% for ¥34,999.80 million. CI
Alfresa unit Cell Resources Partners with Miltenyi Biotec to Advance Cell Culture Automation in Gene Cell Therapy Market MT
Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year Ending March 31, 2024 CI
Alfresa Holdings Corporation Provides Dividend Guidance for the Second Quarter and Year End of Fiscal Year Ending March 31, 2023 CI
Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2023. CI
Alfresa Plans up to 35 Billion Yen Share Buyback; Shares Up 6% MT
Alfresa Holdings Corporation Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Alfresa Holdings Corporation Provides Commemorative Dividend Guidance for the Second Quarter 2024 CI
Alfresa Holdings Corporation Provides Dividend Guidance for the Second Quarter and Year End of Fiscal Year Ending March 31, 2023 CI
Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year Ending March 31, 2024 CI
Alfresa Holdings Corporation announces an Equity Buyback for 21,000,000 shares, representing 10.37% for ¥35,000 million. CI
Alfresa Holdings Corporation Announces Notice Regarding Change for Representative Directors CI
Alfresa Holdings Corporation authorizes a Buyback Plan. CI
Alfresa Holdings Corporation Revises Consolidated Earnings Guidance for the Full Year Ended March 31, 2023 CI
Upcoming 114 Trillion Yen Japan Budget Drives Equities; Orix to Take Stake in REIT Investment Firm for 500 Million Yen MT
Alfresa Unit Receives 51 Million Yen Penalty for Breach of Antimonopoly Act MT
Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023 CI
Alfresa Holdings Corporation Provides Dividend Guidance for the Year Ending March 31, 2023 CI
Chart Alfresa Holdings Corporation
More charts
Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
2,295 JPY
Average target price
2,288 JPY
Spread / Average Target
-0.33%
Consensus
  1. Stock Market
  2. Equities
  3. 2784 Stock
  4. News Alfresa Holdings Corporation
  5. Alfresa Holdings Completes 35 Billion Yen Share Buyback program